The treatment of stage I melanoma of the extremities with regional hyperthermic isolation perfusionErrikos ConstantPlastic and reconstructive surgery
LDH is a prognostic factor in stage IV melanoma patients (pts) but is a predictive factor only for bcl2 antisense treatment efficacy: Re-analysis of GM301 and EORTC18951 randomized trials 8552 Background: Two large studies with identical eligibility criteria and using serum LDH as stratification ...
JAMA OncolCamrelizumab plus apatinib and temozolomide as first-line treatment in patients with advanced acral melanoma:The CAP 03 phase 2 nonrandomized clinical trial(2023) Ann OncolPhase II clinical trial of neoadjuvant anti-PD-1 (toripalimab) combined with axitinib in resectable mucosal melanoma...
Optimal first-line and maintenance treatments for advanced-stage nonsquamous non-small cell lung cancer. Many acceptable treatment options are recommended in the NCCN Clinical Practice Guidelines in Oncology for NSCLC. This article discusses the first-line ... RD Gentzler,JD Patel - 《Journal of th...
Although melanoma is relatively curable with surgical removal if diagnosed in the early stage, its treatment becomes more difficult once the disease reaches the advanced stage because of invasion beyond the dermis and metastasis to distant sites, such as the lung, liver and nervous system [1–3]...
To determine the effect of pregnancy on prognosis in melanoma we investigated 388 women treated for stage 1 primary cutaneous disease during their childbearing years. 85 women had been treated before any pregnancy, 92 during pregnancy, 143 after they had completed all pregnancies, and 68 between pr...
Melanoma represents the most aggressive form of skin cancer, and its incidence continues to rise worldwide. 18F–FDG PET imaging has transformed diagn
COMBINATION OF ENCORAFENIB AND BINIMETINIB AS ADJUVANT TREATMENT FOR RESECTED STAGE II MELANOMA The present invention relates to a pharmaceutical combination for use as adjuvant treatment after resection of a melanoma, wherein the melanoma which has b... JC Vedovato,J Suissa,O Provendier 被引量...
Although the clinical biology and pathogenesis of melanoma are well understood, prognosis remains poor with limited therapeutic options in the metastatic stage of the disease. Melanoma patients have a 5-year survival rate ranging from 98.4% for localized tumor diagnosis, over 62.4% for patients with...
Inequalities in access to healthcare limit physician screening among patients of low socioeconomic status and may result in increased incidence of thick, late stage tumors and decreased survival (Eide et al., 2009; Linos et al., 2009). Among the insured patients, physician factors that inhibit ...